Shopping Cart 0
Cart Subtotal
AED 0

TcLand Expression-Product Pipeline Analysis, 2017 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 8258

Details

Summary

TcLand Expression (TcLand) is a developer of companion diagnostics in immune mediated disorders and biomarkers in solid organ transplantation. The company develops companion diagnostics based on its gene expression biomarkers platform. Its research and development platform develops and validates invasive multi-genes molecular diagnostic blood tests. TcLand's clinical development programs include RA-INF-Dx Test, IMD Dx2, IMD Dx3 and L-TolX test. The company also offers liver transplantation and rheumatoid arthritis services. It partners with pharma and biotech companies for the development of companion diagnostics. TcLand is headquartered in Mulhouse, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company TcLand Expression

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

TcLand Expression Company Overview 4

TcLand Expression Company Snapshot 4

TcLand Expression Pipeline Products and Ongoing Clinical Trials Overview 4

TcLand Expression-Pipeline Analysis Overview 7

TcLand Expression-Key Facts 7

TcLand Expression-Major Products and Services 8

TcLand Expression Pipeline Products by Development Stage 9

TcLand Expression Pipeline Products Overview 11

IMD Dx2 11

IMD Dx2 Product Overview 11

IMD Dx3 12

IMD Dx3 Product Overview 12

L-TolX 13

L-TolX Product Overview 13

RA-INF-Dx 14

RA-INF-Dx Product Overview 14

TcLand Expression-Key Competitors 15

TcLand Expression-Key Employees 16

TcLand Expression-Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

TcLand Expression, Recent Developments 18

Jun 17, 2011: TcLand Expression Receives EUR1.2m From Oseo And ERDF To Support Project In Personalized Medicine 18

Appendix 19

Methodology 19

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

TcLand Expression Pipeline Products by Equipment Type 5

TcLand Expression Pipeline Products by Development Stage 9


List Of Table

List of Tables

TcLand Expression Pipeline Products and Ongoing Clinical Trials Overview 4

TcLand Expression Pipeline Products by Equipment Type 5

TcLand Expression Pipeline Products by Indication 6

TcLand Expression, Key Facts 7

TcLand Expression, Major Products and Services 8

TcLand Expression Number of Pipeline Products by Development Stage 9

TcLand Expression Pipeline Products Summary by Development Stage 10

IMD Dx2-Product Status 11

IMD Dx2-Product Description 11

IMD Dx3-Product Status 12

IMD Dx3-Product Description 12

L-TolX-Product Status 13

L-TolX-Product Description 13

RA-INF-Dx-Product Status 14

RA-INF-Dx-Product Description 14

TcLand Expression, Key Employees 16

Glossary 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

TcLand Expression, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

Company Profile

Company Profile Title

Summary

TcLand Expression (TcLand) is a developer of companion diagnostics in immune mediated disorders and biomarkers in solid organ transplantation. The company develops companion diagnostics based on its gene expression biomarkers platform. Its research and development platform develops and validates invasive multi-genes molecular diagnostic blood tests. TcLand's clinical development programs include RA-INF-Dx Test, IMD Dx2, IMD Dx3 and L-TolX test. The company also offers liver transplantation and rheumatoid arthritis services. It partners with pharma and biotech companies for the development of companion diagnostics. TcLand is headquartered in Mulhouse, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company TcLand Expression

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

TcLand Expression Company Overview 4

TcLand Expression Company Snapshot 4

TcLand Expression Pipeline Products and Ongoing Clinical Trials Overview 4

TcLand Expression-Pipeline Analysis Overview 7

TcLand Expression-Key Facts 7

TcLand Expression-Major Products and Services 8

TcLand Expression Pipeline Products by Development Stage 9

TcLand Expression Pipeline Products Overview 11

IMD Dx2 11

IMD Dx2 Product Overview 11

IMD Dx3 12

IMD Dx3 Product Overview 12

L-TolX 13

L-TolX Product Overview 13

RA-INF-Dx 14

RA-INF-Dx Product Overview 14

TcLand Expression-Key Competitors 15

TcLand Expression-Key Employees 16

TcLand Expression-Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

TcLand Expression, Recent Developments 18

Jun 17, 2011: TcLand Expression Receives EUR1.2m From Oseo And ERDF To Support Project In Personalized Medicine 18

Appendix 19

Methodology 19

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

TcLand Expression Pipeline Products by Equipment Type 5

TcLand Expression Pipeline Products by Development Stage 9


List Of Table

List of Tables

TcLand Expression Pipeline Products and Ongoing Clinical Trials Overview 4

TcLand Expression Pipeline Products by Equipment Type 5

TcLand Expression Pipeline Products by Indication 6

TcLand Expression, Key Facts 7

TcLand Expression, Major Products and Services 8

TcLand Expression Number of Pipeline Products by Development Stage 9

TcLand Expression Pipeline Products Summary by Development Stage 10

IMD Dx2-Product Status 11

IMD Dx2-Product Description 11

IMD Dx3-Product Status 12

IMD Dx3-Product Description 12

L-TolX-Product Status 13

L-TolX-Product Description 13

RA-INF-Dx-Product Status 14

RA-INF-Dx-Product Description 14

TcLand Expression, Key Employees 16

Glossary 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

TcLand Expression, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies